A

Avidity

0 followers

Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-... Read more

Employees

51-200

Links

Org chart

Sarah Boyce's profile picture
Sarah Boyce
President & CEO
Profile photo

Sarah Boyce

Collapse
Michael MacLean's profile picture
Michael MacLean
Chief Financial & Business Officer
Steve Hughes' profile picture
Steve Hughes
Chief Medical Officer
Arthur A. Levin's profile picture
Arthur A. Levin
Chief Scientific Officer
Teresa McCarthy's profile picture
Teresa McCarthy
Chief Human Resources Officer
W. Michael Flanagan's profile picture
W. Michael Flanagan
Chief Scientific & Technical Officer
John W. Wallen III's profile picture
John W. Wallen III
General Counsel
Elizabeth J Ackermann PhD
Senior Vice President Clinical Development
Husam Younis
Senior Vice President
Joseph Johnston
SVP, Regulatory Affairs & Quality
Mike MacLean
Chief Financial Officer
Teresa Brandt, PhD
VP, Regulatory Affairs
Marc Morris, MD JD
VP, Drug Safety & Pharmacovigilance
Anneke Raney
Executive Director, Program And Alliance Management
Sarah Hudson, PhD, PMP®
Sr Director, Program And Alliance Management
  1. Something went wrong loading the org chart, please refresh the page.